Sign in
4

Changes in Ownership

Phathom Pharmaceuticals, Inc. Filed Acc 0000950170-24-067365

Director acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KARBE FRANK Director 2024-05-29 Grant or award +25,000 $10.16 $254,113 44,500 D
Loading xslF345X05/ownership.xml…